衰老的内脏泡细胞在动脉样硬化的各个阶段都是有害的
Bennett G Childs1, Darren J Baker2, Tobias Wijshake3
1Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN 55905, USA.
概括
衰老细胞通过促进炎症和斑块不稳定性而加剧动脉样硬化. 通过使用老化剂清除这些有害细胞,
科学领域:
- 心血管生物学
- 细胞衰老
- 动脉样硬化的发病
背景情况:
- 已知先进的动脉样硬化病变含有衰老细胞.
- 这些衰老细胞在动脉样硬化 (动脉形成) 的具体作用尚不清楚.
研究的目的:
- 研究衰老细胞在动脉生成中的作用.
- 确定消除衰老细胞是否会影响动脉样硬化的进展和斑块特征.
主要方法:
- 使用低密度脂蛋白受体缺乏 (Ldlr-/-) 的小鼠,容易发生动脉样硬化.
- 使用转基因和药理方法在这些小鼠中选择性地消除衰老细胞.
主要成果:
- 在动脉样硬化发展的各个阶段发现衰老细胞是有害的.
- 表达衰老标记的泡性巨细胞在早期积累,通过增加的动脉动脉和炎症性细胞因子驱动病理.
- 在晚期病变中,衰老细胞增加了金属蛋白酶的产生,导致斑块不稳定 (弹性纤维降解,纤维盖薄化).
结论:
- 衰老细胞是动脉样硬化病变 (动脉瘤) 的形成和成熟的关键驱动因素.
- 使用老化剂对老化细胞进行选择性清除是动脉样硬化的潜在治疗策略.
更多相关视频
06:43Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
Published on: December 7, 2013
14.7K
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
8.9K
相关概念视频
Inflammation
63.5K
Overview
63.5K
Atherosclerosis I: Introduction
1.8K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.8K
Coronary Artery Disease II: Pathophysiology
862
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
862
Peripheral Artery Disease I: Introduction
542
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
542
Atherosclerosis III: Management
556
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
556
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
611
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
611
